共 86 条
[1]
Ficarra G., Prignano F., Romagnoli P., Traumatic eosinophilic granuloma of the oral mucosa: a CD30+ (Ki-1) lymphoproliferative disorder?, Oral Oncol, 33, 5, pp. 375-379, (1997)
[2]
Alobeid B., Pan L.X., Milligan L., Budel L., Frizzera G., Eosinophil-rich CD30+ lymphoproliferative disorder of the oral mucosa. A form of “traumatic eosinophilic granuloma, Am J Clin Pathol, 121, 1, pp. 43-50, (2004)
[3]
Sciallis A.P., Law M.E., Inwards D.J., McClure R.F., Macon W.R., Kurtin P.J., Dogan A., Feldman A.L., Mucosal CD30-positive T-cell lymphoproliferations of the head and neck show a clinicopathologic spectrum similar to cutaneous CD30-positive T-cell lymphoproliferative disorders, Mod Pathol, 25, 7, pp. 983-992, (2012)
[4]
Wang W., Cai Y., Sheng W., Lu H., Li X., The spectrum of primary mucosal CD30-positive T-cell lymphoproliferative disorders of the head and neck, Oral Surg Oral Med Oral Pathol Oral Radiol, 117, 1, pp. 96-104, (2014)
[5]
Agarwal M., Shenjere P., Blewitt R.W., Hall G., Sloan P., Pigadas N., Banerjee S.S., CD30-positive T-cell lymphoproliferative disorder of the oral mucosa—an indolent lesion: report of 4 cases, Int J Surg Pathol, 16, 3, pp. 286-290, (2008)
[6]
Aoki R., Karube K., Sugita Y., Nomura Y., Shimizu K., Kimura Y., Hashikawa K., Suefuji N., Kikuchi M., Ohshima K., Distribution of malignant lymphoma in Japan: analysis of 2260 cases, 2001–2006, Pathol Int, 58, 3, pp. 174-182, (2008)
[7]
Laurini J.A., Perry A.M., Boilesen E., Diebold J., Maclennan K.A., Muller-Hermelink H.K., Nathwani B.N., Armitage J.O., Weisenburger D.D., Classification of non-Hodgkin lymphoma in Central and South America: a review of 1028 cases, Blood, 120, 24, pp. 4795-4801, (2012)
[8]
Pongpruttipan T., Sukpanichnant S., Assanasen T., Wannakrairot P., Boonsakan P., Kanoksil W., Kayasut K., Mitarnun W., Khuhapinant A., Bunworasate U., Puavilai T., Bedavanija A., Garcia-Herrera A., Campo E., Cook J.R., Choi J., Swerdlow S.H., Extranodal NK/T-cell lymphoma, nasal type, includes cases of natural killer cell and αβ, γδ, and αβ/γδ T-cell origin: a comprehensive clinicopathologic and phenotypic study, Am J Surg Pathol, 36, 4, pp. 481-499, (2012)
[9]
Iqbal J., Kucuk C., Deleeuw R.J., Srivastava G., Tam W., Geng H., Klinkebiel D., Christman J.K., Patel K., Cao K., Shen L., Dybkaer K., Tsui I.F., Ali H., Shimizu N., Au W.Y., Lam W.L., Chan W.C., Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies, Leukemia, 23, 6, pp. 1139-1151, (2009)
[10]
Karube K., Nakagawa M., Tsuzuki S., Takeuchi I., Honma K., Nakashima Y., Shimizu N., Ko Y.H., Morishima Y., Ohshima K., Nakamura S., Seto M., Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses, Blood, 118, 12, pp. 3195-3204, (2011)